Anterior vs Cohere Health (2026)
The two prior authorization engines in the index, both graded A on AI centrality, and the comparison turns entirely on what each will show you about how it decides. Cohere states the principle that should govern this whole category: the AI auto approves and never auto denies, with clinicians deciding the rest, and it backs that with the strongest evidence in the lane, including provider satisfaction measured from the counterparty rather than the buyer. Anterior is the broader reasoning layer, spanning prior authorization, risk adjustment, and care management across plans covering a reported 50 million plus lives, and it earns credit for automating approvals specifically, but it does not publish the threshold for human review or confirm it cannot deny autonomously, and its headline accuracy figure carries no methodology. Both share the governance gap that matters most, models trained on historical authorization data can reinforce denial patterns. If your failure mode is prior authorization with a stated, auditable safety asymmetry, start with Cohere. If your failure mode is wanting one reasoning layer across several payer workflows, start with Anterior, and require the autonomous denial boundary in the contract.
- A broad clinical reasoning footprint: prior authorization, risk adjustment, care management, and payment integrity from one reasoning layer across plans covering a reported 50 million plus lives, positioned against general purpose generative AI, graded A on AI centrality.
- The favourable automation direction credited: a reported 76 percent increase in auto approvals, automating the direction that costs the plan money on error rather than costing a patient care, graded B on autonomy.
- A proprietary clinical reasoning architecture aimed at the specific task of matching a patient's documented picture to a payer's medical necessity criteria, rather than summarising a chart.
- The strongest evidence in this lane: a reported 15 million plus prior authorization submissions through the APIs, 47 million interactions annually, and provider satisfaction measured from the counterparty at 94 percent with an NPS of 67, graded A on clinical evidence where Anterior grades C.
- The safety asymmetry stated and architected, not just tuned: auto approve up to 85 percent in real time, never auto deny, remainder to a clinician, graded A on autonomy where Anterior leaves the autonomous denial boundary unpublished at B.
- Reaches the whole provider network: submissions by phone, fax, and web as well as EHR integration, graded A on interoperability, with named plans including Humana and Geisinger.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Anterior and Cohere Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Anterior | Cohere Health |
|---|---|---|
| Primary category | RCM & Prior Auth AI | RCM & Prior Auth AI |
| Founded | 2022 | Not recorded |
| Headquarters | New York, New York, United States | Boston, Massachusetts |
| Website | anterior.com | coherehealth.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Anterior its top capability grade on AI Centrality. Set against Cohere Health, Anterior does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, Model and Technology Transparency and AI Governance and Bias Disclosure. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
The AI Health Index awards Cohere Health its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Clinical and Operational Evidence. Set against Anterior, Cohere Health grades higher on several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and Clinical and Operational Evidence. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, July 2026
Questions buyers ask
Should we choose Anterior or Cohere Health?
The AI Health Index grades Cohere Health higher than Anterior on every axis that separates them, several axes, including Autonomy and Oversight Model, Model Supply Chain Disclosure and Clinical and Operational Evidence. Anterior does not grade higher on any scored axis.
Where do Anterior and Cohere Health differ most?
The widest separation the AI Health Index records between Anterior and Cohere Health is on Model Supply Chain Disclosure, where Anterior grades D and Cohere Health grades B. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Anterior and Cohere Health grade the same?
The AI Health Index grades Anterior and Cohere Health the same on several axes, including AI Centrality, Model and Technology Transparency and AI Governance and Bias Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Anterior and Cohere Health not disclosed?
At the last review, at least one of Anterior and Cohere Health published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
This is the sharpest pairing in the payer side lane because both do prior authorization and both grade A on AI centrality, so the split is entirely about disclosure and safety architecture. Cohere states the asymmetry that is the whole safety argument, auto approve but never auto deny, and backs it with the strongest evidence in the lane including provider measured satisfaction, graded A on autonomy and evidence.
Anterior reports a 76 percent increase in auto approvals, which earns credit for directionality at B, but does not publish the confidence threshold for routing to a human or whether it is architecturally barred from autonomous denials, the single most consequential disclosure here; it also grades C on model transparency for a 99.24 percent figure with no methodology and C on clinical evidence for vendor generated numbers.
Both grade C on governance, the shared and load bearing caution, since models on historical authorization data can reinforce denial patterns and documentation completeness varies with provider resourcing. The 2026 CMS prior authorization rules and emerging state limits on AI driven denials bear directly on both. Anterior carries the full thirteen axes, Cohere roughly six. Neither publishes pricing.